Esta guía aborda aspectos relacionados con el diagnóstico y el tratamiento médico y quirúrjico del vólvulo de colon en el adulto...
Hacer recomendaciones basadas en la mejor evidencia disponible para el diagnóstico clínico y paraclínico de las Distrofias Musculares.
Hacer recomendaciones basadas en la mejor evidencia disponible para el tratamiento y rehabilitación de las personas con Distrofia Muscular.
Hacer recomendaciones basa...
The overall objective of the guidelines is to provide public health approach guidance on evidencebased practices for testing, treating and managing LTBI in individuals with the highest risk of progression to active disease. The guidelines are expected to provide the basis and rationale for the developmen...
The objective of this guideline is to provide recommendations on the intake of free sugars to reduce the risk of NCDs in adults and children, with a particular focus on the prevention and control of unhealthy weight gain and dental caries. The recommendations in this guideline can be used by policy-make...
El objetivo principal de esta Guía es recoger recomendaciones para el diagnóstico y el tratamiento de mujeres con cáncer de mama metastásico....
Neoplasias de la Mama/diagnóstico,
Neoplasias de la Mama/terapia,
Metástasis de la Neoplasia,
Trastuzumab/uso terapéutico,
Tamoxifeno/uso terapéutico,
Goserelina/uso terapéutico,
Inhibidores de la Aromatasa/uso terapéutico,
Everolimus/uso terapéutico,
Tomografía de Emisión de Positrones/métodos,
Tomografía Computarizada por Tomografía de Emisión de Positrones/métodos,
Neoplasias Óseas/secundario,
Biopsia,
Enfoque GRADE,
Antineoplásicos/administración & dosificación
El objetivo principal de la guía es proporcionar a los profesionales sanitarios, recomendaciones para la prevención, el diagnóstico y el manejo terapéutico de los pacientes con Linfoma B Difuso de célula grande (LBDCG), que presentan (o tienen riesgo de) afectación leptomeníngea o del parénquima ...
Linfoma de Células B Grandes Difuso/tratamiento farmacológico,
Linfoma de Células B Grandes Difuso/diagnóstico,
Enfermedades del Sistema Nervioso Central/etiología,
Punción Espinal/métodos,
Biopsia/métodos,
Espectroscopía de Resonancia Magnética/métodos,
Metotrexato/uso terapéutico,
Rituximab/uso terapéutico,
Antineoplásicos/uso terapéutico,
Enfoque GRADE,
Enfermedades del Sistema Nervioso Central/prevención & control
In 2011 WHO conditionally recommended the use of at least 36 months of isoniazid preventive therapy (IPT) (as a proxy for lifelong or continuous treatment) for people living with HIV in high TB-prevalence and transmission settings. The evidence of the benefits and harms of 36-month IPT compared to 6-mont...
In 2015 WHO updated the mhGAP guidelines, first issued in 2009, for the management of mental, neurological and substance use (MNS) disorders. In order to reduce the gap and to enhance the capacity of Member States to respond to the growing challenge, the World Health Organization (WHO) developed the Ment...
This early-release guideline makes available two key recommendations that were developed during the revision process in 2015. First, antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count. Second, the use of daily oral pre-exposure prophylaxis (PrEP) is recomme...
Meningococcal meningitis is a bacterial form of meningitis, a serious infection of the meninges (brain membrane). It can cause severe brain damage and is fatal in 50% of cases if untreated. It provides a concise overview of the World Health Organization (WHO) strategy to detect and respond to meningitis ...
